SiRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to gag by CD8+ T cells from HIV-1-infected individuals

Journal of Clinical Immunology

Volumn 29, Issue 5, 2009, Pages 637-645

  Breton, Gaëlle ^a   Yassine Diab, Bader ^b,c   Cohn, Lillian ^a   Boulassel, Mohamed Rachid ^e   Routy, Jean Pierre ^d,e   Sékaly, Rafick Pierre ^b,c,d   Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

CD8+ T cell; Dendritic cells; HIV 1 gag; PD L1; PD L2; SiRNA

Indexed keywords

GAG PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; DENDRITIC CELL; DRUG EFFECT; ELECTROPORATION; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGRAMMED DEATH 1 GENE; PROGRAMMED DEATH 2 GENE; RNA INTERFERENCE; UPREGULATION;

EID: 69249210916     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-009-9313-9     Document Type: Article

References (32)

1. + T cells Blood 107 12 4781 4789
2. SC Zimmerli A Harari C Cellerai F Vallelian PA Bart G Pantaleo 2005 HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells Proc Natl Acad Sci U S A 102 20 7239 7244
3. + T cells is reflected by their avidity, polyfunctionality, and clonal turnover J Exp Med 204 10 2473 2485
4. P Shankar M Russo B Harnisch M Patterson P Skolnik J Lieberman 2000 Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection Blood 96 9 3094 3101
5. D Zhang P Shankar Z Xu B Harnisch G Chen C Lange SJ Lee H Valdez MM Lederman J Lieberman 2003 Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic Blood 101 1 226 235
6. DL Barber EJ Wherry D Masopust B Zhu JP Allison AH Sharpe GJ Freeman R Ahmed 2006 Restoring function in exhausted CD8 T cells during chronic viral infection Nature 439 7077 682 687
7. + T cells leads to reversible immune dysfunction Nat Med 12 10 1198 1202
8. CL Day DE Kaufmann P Kiepiela JA Brown ES Moodley S Reddy EW Mackey JD Miller AJ Leslie C DePierres Z Mncube J Duraiswamy B Zhu Q Eichbaum M Altfeld EJ Wherry HM Coovadia PJ Goulder P Klenerman R Ahmed GJ Freeman BD Walker 2006 PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression Nature 443 7109 350 354
9. + T cell survival in HIV infection J Exp Med 203 10 2281 2292
10. V Velu K Titanji B Zhu S Husain A Pladevega L Lai TH Vanderford L Chennareddi G Silvestri GJ Freeman R Ahmed RR Amara 2009 Enhancing SIV-specific immunity in vivo by PD-1 blockade Nature 458 7235 206 210
11. AH Sharpe EJ Wherry R Ahmed GJ Freeman 2007 The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection Nat Immunol 8 3 239 245
12. ME Keir MJ Butte GJ Freeman AH Sharpe 2008 PD-1 and its ligands in tolerance and immunity Annu Rev Immunol 26 677 704
13. RJ Greenwald GJ Freeman AH Sharpe 2005 The B7 family revisited Annu Rev Immunol 23 515 548
14. GJ Freeman AJ Long Y Iwai K Bourque T Chernova H Nishimura LJ Fitz N Malenkovich T Okazaki MC Byrne HF Horton L Fouser L Carter V Ling MR Bowman BM Carreno M Collins CR Wood T Honjo 2000 Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J Exp Med 192 7 1027 1034
15. JA Brown DM Dorfman FR Ma EL Sullivan O Munoz CR Wood EA Greenfield GJ Freeman 2003 Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production J Immunol 170 3 1257 1266
16. Y Latchman CR Wood T Chernova D Chaudhary M Borde I Chernova Y Iwai AJ Long JA Brown R Nunes EA Greenfield K Bourque VA Boussiotis LL Carter BM Carreno N Malenkovich H Nishimura T Okazaki T Honjo AH Sharpe GJ Freeman 2001 PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat Immunol 2 3 261 268
17. SY Tseng M Otsuji K Gorski X Huang JE Slansky SI Pai A Shalabi T Shin DM Pardoll H Tsuchiya 2001 B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells J Exp Med 193 7 839 846
18. D Trabattoni M Saresella M Biasin A Boasso L Piacentini P Ferrante H Dong R Maserati GM Shearer L Chen M Clerici 2003 B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression Blood 101 7 2514 2520
19. X Wang Z Zhang S Zhang J Fu J Yao Y Jiao H Wu FS Wang 2008 B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection Eur J Immunol 38 11 3226 3236
20. P Dubsky H Ueno B Piqueras J Connolly J Banchereau AK Palucka 2005 Human dendritic cell subsets for vaccination J Clin Immunol 25 6 551 572
21. CR Rinaldo 2009 Dendritic cell-based human immunodeficiency virus vaccine J Intern Med 265 1 138 158
22. W Lu LC Arraes WT Ferreira JM Andrieu 2004 Therapeutic dendritic-cell vaccine for chronic HIV-1 infection Nat Med 10 12 1359 1365
23. F García M Lejeune N Climent C Gil J Alcamí V Morente L Alós A Ruiz J Setoain E Fumero P Castro A López A Cruceta C Piera E Florence A Pereira A Libois N González M Guilá M Caballero F Lomeña J Joseph JM Miró T Pumarola M Plana JM Gatell T Gallart 2005 Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection J Infect Dis 191 10 1680 1685
24. F Ide T Nakamura M Tomizawa A Kawana-Tachikawa T Odawara N Hosoya A Iwamoto 2006 Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial J Med Virol 78 6 711 718
25. NC Connolly TL Whiteside C Wilson V Kondragunta CR Rinaldo SA Riddler 2008 Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals Clin Vaccine Immunol 15 2 284 292
26. SJ Ha SN Mueller EJ Wherry DL Barber RD Aubert AH Sharpe GJ Freeman R Ahmed 2008 Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection J Exp Med 205 3 543 555
27. RM Steinman H Hemmi 2006 Dendritic cells: translating innate to adaptive immunity Curr Top Microbiol Immunol 311 17 58
28. + T cells correlates with disease progression and defines a reversible immune dysfunction Nat Immunol 8 11 1246 1254
29. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection Nat Immunol 10 1 29 37
30. RB Jones LC Ndhlovu JD Barbour PM Sheth AR Jha BR Long JC Wong M Satkunarajah M Schweneker JM Chapman G Gyenes B Vali MD Hyrcza FY Yue C Kovacs A Sassi M Loutfy R Halpenny D Persad G Spotts FM Hecht TW Chun JM McCune R Kaul JM Rini DF Nixon MA Ostrowski 2008 Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection J Exp Med 205 12 2763 2779
31. + T cells in a spectrum of human MHC I haplotypes Proc Natl Acad Sci U S A 104 4 1289 1294
32. E Song P Zhu SK Lee D Chowdhury S Kussman DM Dykxhoorn Y Feng D Palliser DB Weiner P Shankar WA Marasco J Lieberman 2005 Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat Biotechnol 23 6 709 717